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Abstract
Ionotropic GABA receptors are the targets for several classes of insecticides. One of the most widely-studied insect GABA
receptors is RDL (resistance to dieldrin), originally isolated from Drosophila melanogaster. RDL undergoes alternative splicing
and RNA editing, which influence the potency of GABA. Most work has focussed on minority isoforms. Here, we report the
first characterisation of the predominant native splice variant and RNA edit, combining functional characterisation with
molecular modelling of the agonist-binding region. The relative order of agonist potency is GABA. muscimol. TACA. b-
alanine. The I/V edit does not alter the potency of GABA compared to RDLbd. Docking calculations suggest that these
agonists bind and activate RDLbdI/V through a similar binding mode. TACA and b-alanine are predicted to bind with lower
affinity than GABA, potentially explaining their lower potency, whereas the lower potency of muscimol and isoguvacine
cannot be explained structurally from the docking calculations. The A
301S (resistance to dieldrin) mutation reduced the
potency of antagonists picrotoxin, fipronil and pyrafluprole but the I/V edit had no measurable effect. Ivermectin
suppressed responses to GABA of RDLbdI/V, RDLbd and RDLbdI/VA301S. The dieldrin resistant variant also showed reduced
sensitivity to Ivermectin. This study of a highly abundant insect GABA receptor isoform will help the design of new
insecticides.
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Introduction
GABA-gated chloride channels (GABAARs) are of considerable
interest in neuroscience, medicine and drug discovery. This is due
to several factors. First, they are widely distributed throughout the
nervous systems of vertebrates [1,2] and invertebrates [3–5].
Secondly, they are the targets of a large number of diverse drugs,
including anxiolytic and anticonvulsant benzodiazepines [6] as
well as anaesthetics such as propofol [7] and steroids [8]. Thirdly,
they are targets of several classes of commercially-important
insecticides, such as cyclodienes (including dieldrin) and fipronil
[4], while in nematodes they are targeted by piperazine [9]. A
better understanding of the molecular basis of GABAAR function
will therefore impact strongly on several areas of neuroscience.
The major GABAAR of the fruit-fly, Drosophila melanogaster, is the
RDL (resistance to dieldrin) subunit [10,11], which has played an
important strategic role in our understanding of how ligands
regulate GABAARs. Not only is it from a model organism with the
most extensive genetic toolkit, but the receptor (unlike nearly all
vertebrate GABAARs) readily expresses robust, functional homo-
oligomers, assisting the interpretation of structure-function studies
and molecular simulation studies aimed at understanding how
ligands interact with the receptor. RDL was the first invertebrate
GABA receptor to be cloned and functionally expressed, initially
from the fruit fly [10,11], and subsequently from many other
insects [12–14]. In most insects, cyclodiene resistance is conferred
by an alanine-to-serine substitution, but an alanine-to-glycine
replacement has also been observed [15]. Identical resistance
alleles have been found in geographically distant regions pointing
towards multiple origins of resistance [16]. This RDL A
301S
mutation results in high levels (.4000-fold) of resistance to the
cyclodiene dieldrin [17] and the structurally-related plant com-
pound picrotoxin, a mixture of the two compounds picrotoxinin
and picrotin.
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studied as a model of the effects of mRNA editing and splicing –
major sources of phenotypic diversity outside the genome.
However, studies to date suffer from a major weakness, in that
they are performed only on rare edit/splice isoforms [18]. This
paper aims to address this problem.
Alternative splicing in two locations of RDL yields two variants
each for exons 3 (variants a and b) and 6 (variants c and d). All four
possible splice isoforms are transcribed [10]. This alternative
splicing affects agonist potency [19]. In addition, Rdl undergoes A-
to-I RNA editing [20] which leads to the substitution of four
amino acid residues in functionally significant regions: R122G
(extracellular N-terminal), I283V (TM1), N294D (intracellular
TM1–TM2 loop) and M360V (intracellular TM3–TM4 loop).
The combination of alternative splicing and RNA editing
generates considerable variation in the physiology and pharma-
cology of RDL. For example, Es-Salah et al. [21] showed that the
edit site R122G, located between ligand binding loops D and A,
affects agonist potency and reduces sensitivity to fipronil.
Furthermore, it is interesting to note that Fisher [22] found that
the large intracellular loop between TM3 and TM4, which
contains the site of the M360V edit, influences GABAR
desensitisation kinetics and GABA sensitivity.
In a comprehensive analysis of the impact of RNA A-to-I
editing of Drosophila RDL in different splice backgrounds, Jones
et al. [18] showed that alternative splicing and RNA editing have
a combined effect on GABA potency and the extent of RNA
editing varies between splice variants and also depends on the
developmental stage. The bd isoform was the predominant splice
variant with transcript levels 26 times greater than the ad form (the
second most abundant variant) and it was the only splice variant to
be edited at all four sites. Of the four edits, I283V was the most
abundant across all life stages. However, despite being the
commonest variant and therefore the most abundant form of
RDL exposed to insecticides, its physiology and pharmacology are
not well studied. Prior to appreciation of the potential impact of
editing and splicing, most studies used the RDLac variant which
has been shown to be the least abundantly expressed of the four
splice variants. Here we provide the first detailed characterisation
of heterologously expressed RDLbdI/V, the most abundant native
form of the Drosophila RDL GABA receptor.
Materials and Methods
The RDLbd splice variant with and without the I283V edit [18]
was the starting point for site-directed mutagenesis. The Quik
Change Site-Directed Mutagenesis Kit (Stratagene) was used to
introduce an alanine to serine mutation (gcgctc to tcgctc) into the
RdlbdI283V (RdlbdI/V) variant to produce the dieldrin-resistant
mutations RdlbdI283VA
301S (RdlbdI/VA
301S). To help the reader
differentiate between a natural editing site and a mutation we have
put the mutation in superscript. The sequences of the forward and
reverse primers were:
59 CAACGCCGGCGCGTGTGTCGCTCGGTGTGA-
CAACC 39 (sense)
59 GGTTGTCACACCGAGCGACA-
CACGCGCCGGCGTTG 39 (antisense)
(altered nucleotide in bold). The presence of the mutation was
confirmed by sequencing. Templates were linearised with XbaI,
and capped RNA was synthesised using the T7 mMessage
Machine Kit (Ambion).
Two-electrode Voltage-clamp Electrophysiology
Stage V-VI oocytes from Xenopus laevis were purchased from the
European Xenopus Resource Centre at the University of Ports-
mouth and defolliculated manually after a 1 h incubation with
collagenase type 1A (2 mg/ml) (Sigma) and injected with 50 ng (at
1 ng/nl) cRNA encoding RDLbd, RDLbdI/V or RDLbdI/VA
301S.
Oocytes were incubated in filter-sterilized, standard oocyte saline
(SOS) consisting of: 100 mM NaCl, 2 mM KCl, 1.8 mM CaCl2,
1 mM MgCl2, 5 mM HEPES (pH 7.6) and supplemented with
100 U/ml penicillin, 100 mg/ml streptomycin, 50 mg/ml genta-
micin and 2.5 mM sodium pyruvate at 18uC. Currents were
recorded 24–48 h post-injection. Oocytes from at least 3 animals
were used for each experiment.
Xenopus oocytes were voltage clamped at 2100 mV under 2-
electrode voltage clamp. Only oocytes which yielded stable
responses to at least three control concentrations of GABA applied
at 2 min intervals were used. Agonists were obtained from Sigma
(UK) and dissolved in SOS. Concentration-response curves were
constructed by challenging the oocyte to increasing concentrations
of agonist for 5 s at a flow-rate of 4 ml/min with at least 2 min
between challenges to reduce the effects of desensitisation.
Responses were normalised to a maximal GABA-evoked response.
Picrotoxin (PTX) (Sigma, UK), ivermectin (IVM) (Sigma, UK),
fipronil and pyrafluprole (gifts from Dr Lance Hammerland,
Merial Animal Health) were first dissolved in dimethylsulphoxide
(DMSO) and then diluted in SOS to the required concentrations.
Responses to GABA were not affected by DMSO at its final
concentration (1% v/v). To determine inhibitory activity, the
antagonists were added after three successful control applications
of 1 mM GABA. Oocytes were pre-treated with the antagonists
for 3 min followed by co-application of antagonist and GABA for
5s .
Data Analysis
Data are presented as mean 6 SEM of three to five
independent experiments. Agonist oocyte data were normalised
to the maximal current obtained from that oocyte and non-linear
regression was used to fit the concentration-response data for each
oocyte obtain the pEC50 values, fitting the normalised data to a 3-
parameter sigmoidal function:
I~
Imax
Imaxze
{ x{EC50 ðÞ
b
 !
where I is the normalized current, Imax is the maximum current
evoked by that compound, x is the concentration, EC50 is the
concentration that evokes half the maximum current, and b is the
slope. To obtain the concentration-inhibition relationship, the
response after co-application of agonist and antagonist was
normalised to the control response against GABA and analysed
to obtain the IC50 value. Statistical tests were performed using a 1-
way ANOVA on the EC50s with post-hoc t-tests with a significance
level of P,0.05.
Homology Modelling
Models of RDLbd with I283V and additionally R122G and
N294D were constructed using MODELLER 9.9 [23] based on
the structure of the Caenorhabditis elegans GluCla glutamate-gated
chloride channel [24]. The sequence alignment was generated
using ClustalW [25,26]. The best models were selected based on
the MODELLER objective function, the DOPE score and
PROCHECK Ramachandran plot statistics. R122G and
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site and will thus presumably have no influence on the binding
models.
Agonist Docking
The five agonists, GABA, TACA, b-alanine, isoguvacine and
muscimol, were constructed in Maestro version 9.3 (Schro ¨dinger,
LLC, New York, NY, 2012 academic version). All agonists were
docked in their zwitterionic form in which they are expected to be
found at physiological pH [27–30]. Since Autodock Vina does not
account for potential flexibility in ring structures, five different ring
conformations for isoguvacine were generated in Maestro.
Protein and ligands were prepared for docking using AutoDock
Tools [31] and docking calculations were performed with
AutoDock Vina [32]. The centre of the search box was defined
from the centre of mass of E204 (chain E) and R111 (chain A), and
the size of the box was 17617620 A ˚ 3. A maximum of 20
generated binding models for each input structure was requested
with a maximum energy difference between the best and worst
binding models of 5 kcal/mol. The sidechains of E204 (chain E)
and R111 (chain A), in each end of the binding pocket, were
treated as flexible in the ligand docking.
Statistical Analyses
All numerical data are presented as mean 6 standard error of
the mean. Statistical tests of significance are given in the text.
Ethics
Since no experiments were conducted on living animals or on
humans, ethics approval for this study is not required.
Results
Agonist Profile – functional and Modelling Studies
Oocytes expressing RDLbd, RDLbdI/V or RDLbdI/VA
301S
produced concentration-dependent inward currents in response to
bath-applied GABA over the range 10
26 to 10
23 M (Fig. 1A). We
could not obtain saturation of responses to muscimol, isoguvacine
or TACA within the limits of solubility (see Fig. 1B). Nonetheless,
fits to the curves allowed the EC50s to be estimated and there is no
statistically significant difference (F(2,95)=1.3, P=0.27) for
GABA pEC50s between the three RDLbd subtypes (RDLbd:
4.2460.09, RDLbdI/V: 4.3460.07, and RDLbdI/
VA
301S:4.3460.06). Maximum current amplitudes were recorded
above ,1 mM GABA.
Five GABA analogues (GABA, TACA, b-alanine, muscimol
and isoguvacine) were tested for agonist activity on RDLbdI/V
(Fig. 1). Muscimol, TACA and b-alanine induced concentration-
dependent inward currents. Responses to isoguvacine did not
saturate at 3 mM and produced non-specific responses at 10 mM
in uninjected oocytes. Responses to TACA, muscimol and b-
alanine also failed to saturate at 6 mM, 3 mM and 10 mM
respectively, and were insoluble at higher concentrations. It is
therefore not clear where the true saturation concentration is, so
estimates of pEC50 are therefore less trustworthy. With the above
caveat regarding the failure to reach saturation, fits to the
concentration/response curves suggest that the relative order of
agonist potency of the RDLbdI/V isoforms is as follows (pEC50si n
parentheses): GABA (4.4260.05).muscimol (4.0260.04) .
TACA (3.5860.04).b-alanine (2.5160.03). A 1-way ANOVA
revealed that these differences are statistically significant
(F(4,255)=274, P,0.0001) and post-hoc unpaired t-tests indicated
that pEC50s of muscimol (P,0.001), TACA (P=0.001), and b-
Figure 1. Concentration response curves for GABA and
analogues mediated by variants of the RDLbd splice variant.
(A) Concentration response curves for the three RDL subunits: RDLbd,
RDLbdIV and RDLbdIVA
301S to GABA (structure inserted). Data were
normalised to 1 mM GABA. Each data point is the mean 6 S.E.M from
four to six oocytes from at least three separate frogs. Representative
responses to 100 mM GABA are shown for each variant. Scale bars
indicate 0.5 mA, 1 s. (B) Concentration response curves showing
responses elicited by GABA and analogues at RDLbdIV receptors in
Xenopus oocytes. GABA is the most potent agonist, and the rank order
is GABA. muscimol. TACA..b-alanine. Isoguvacine did not reach
saturation. Data were normalised to the response to 1 mM GABA. Each
data point represents mean6S.E.M from five to eight oocytes. (C) The
chemical structures of the agonists tested in the present study: GABA
(c-amino butyric acid), TACA (trans-4-aminocrotonic acid), b-alanine,
muscimol and isoguvacine.
doi:10.1371/journal.pone.0097468.g001
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GABA.
We next set out to establish whether molecular docking
simulations might explain the agonist profile of this receptor.
TACA and isoguvacine share the GABA skeleton with an amine
group and a carboxylic acid group connected by three carbon
atoms (excluding the carbon atom in the carboxylic acid group).
Muscimol contains a similar skeleton with a hydroxyl group
instead of the carboxylic acid group. b-alanine has both the amine
group and the carboxylic acid group but only two connecting
carbon atoms. These structural similarities (See Fig. 1C) suggest
that the five agonists might share a similar binding mode with
overlapping positions of the amine and the acid except for b-
alanine, which is possibly too short to span the distance required
between the two groups.
Earlier modelling studies for the GABAC receptor predict that
GABA in this receptor forms salt bridges to R104 (R111 in
RDLbd) and to E194 and E196 (E202 and E204 in RDLbd)
[33,34]. For RDL, F206 and Y254 are believed to form cation-p
interactions with GABA whereas F146 does not seem to contribute
to cation-p interactions [35].
To explore whether a similar binding mode for the different
ligands could be identified, the five agonists were docked into the
agonist binding site in the extracellular domain of a homology
model of the RDLbd receptor. The residues R111 and E204 were
used to define the binding pocket (Fig. 2). For each ligand, a
variety of binding modes was generated, both inside and outside
the binding site. The analysis was focused on binding modes inside
the binding site, where the agonists would possibly make
interactions with R111, E202 or E204, F206 and/or Y254 as
suggested by previous studies for GABA.
The two best-scoring binding models of GABA (both with a
predicted affinity of 25.0 kcal/mol; third-best affinity is 2
4.7 kcal/mol) are oriented in the same way. They illustrate a
binding mode in which the carboxylate of GABA interacts with
R111 through hydrogen bonds and ionic interactions, and where
the amine interacts through hydrogen bonds and ionic interactions
with E204 and forms hydrogen bonds to backbone oxygen atoms
on S205 and F206 (Fig. 2B). In the best-scoring model, Y254 is
best positioned for cation-p interactions, but also the side chains of
F206 and F146 are within 4.5 A ˚ of the positively charged amine
group. This is the best scoring binding model, and additionally it
fits well with earlier discussed data regarding interactions with
R111, E204, Y254 and partly F206. Hence, this model is chosen
as a model for GABA binding in RDLbd.
For TACA, which is very similar to GABA except for the
presence of a double bond in the carbon chain connecting the
carboxylate and the amine, the three generated binding modes
with the highest affinity are positioned very similar to the chosen
binding model for GABA (Fig. 2C). These three binding models
with the carboxylate pointing towards R111 and the amine
towards E204, and thus partly sandwiched between F206 and
Y254, all have predicted affinities of 24.7 kcal/mol. The fourth-
best model has an affinity of 24.0 kcal/mol. The range of
interactions possible for this binding mode is more or less the same
as for GABA itself, except that the TACA carboxylate group
additionally forms a hydrogen bond to the S176 hydroxyl group.
Despite the lack of a carbon atom in the skeleton of b-alanine
relative to GABA and TACA, the three binding models for b-
alanine with the highest affinities are positioned similar to the
chosen binding model for GABA (Fig. 3D). The amine group
superimposes with the one in GABA, and the R111 sidechain is
rearranged to allow interaction with the carboxylate of the smaller
b-alanine molecule. A hydrogen bond to S176 also seems likely.
The predicted affinities for these three binding modes are 2
4.3 kcal/mol, 24.2 kcal/mol and 23.9 kcal/mol. The affinity for
the fourth best model is 23.6 kcal/mol.
The binding model for muscimol with the largest predicted
affinity is overall oriented in the same way as the chosen GABA
binding model with the amine pointing towards E204 and the
negatively charged oxygen atom pointing towards R111 (Fig. 2E).
The amine forms the same interactions as the amine in GABA,
while the negatively charged oxygen atom interacts with R111.
The predicted affinity for this binding mode is 25.2 kcal/mol
while the next best one is 25.1 kcal/mol.
Different starting conformations were used for isoguvacine as
AutoDock Vina does not automatically vary the conformation of
flexible rings during the docking. Thus, more poses were
generated than for the other docked ligands. The best ranked
binding models for each conformation can be clustered into two
different binding modes, one in which the overall orientation is
similar to the GABA binding model (Fig. 2F) and another, more or
less rotated 90u around an axis perpendicular to the 6-membered
ring, where the carboxylate group is still pointing towards R111,
but the amine points directly towards backbone oxygen of F206
(Fig. 2F). Such an overall orientation is also seen for some binding
modes for the other ligands, although binding modes with this
orientation have a lower predicted affinity compared to modes
with the amine pointing towards E204. For isoguvacine, the
predicted affinity for the best model from each of the two clusters
is 25.5 kcal/mol for the less GABA-like mode and 25.2 kcal/mol
for the GABA-like mode. For the GABA-like binding mode, the
amine interacts with E204. No other hydrogen bonds from the
amine seem possible, and it is not very well positioned for forming
cation-p interactions though the sidechains of Y254 and F146 are
within 4.5 A ˚ of the amine. The carboxylate interacts with R111
and S176. For the other binding mode (Fig. 2G) which is predicted
to have a higher affinity, the carboxylate again interacts with
R111, whereas the amine is positioned quite well for cation-p
interactions with both Y254 and F206 and also forms a hydrogen
bond to the backbone oxygen of F206. Judging from the scores
alone, the less GABA-like binding mode (Fig. 2G) appears most
physiologically relevant, whereas the GABA-like mode (Fig. 2F)
seems attractive as it fits better with the proposed binding modes
for the other agonists (as the comparison in Fig. 2H illustrates).
Actions of Picrotoxin, Fipronil, Pyrafluprole and
Invermectin
Given the importance of insect GABAARs in pest control, and
the paucity of studies on the overwhelmingly predominant isoform
of RDL, we next considered the antagonist profile of RDLbdI/V.
The amplitude of GABA-evoked currents mediated by RDLbd, the
edited RDLbdI/V and the A
301S point mutated RDLbdI/VA
301S
were reduced by bath-applied PTX in a concentration-dependent
manner (Fig. 3), with pIC50 values estimated from fitting the
dependency of inhibition on PTX concentration to be 6.4660.18,
6.4460.13 and 5.6760.19, respectively. These values were
statistically significantly different (F(2,60)=5.49, P,0.001). While
1 mM PTX reduced GABA responses mediated by wild-type and
RDLbdI/V receptors by more than 50%, the same concentration
of PTX reduced responses of the A
301S only by about 30% (Fig. 3).
When fipronil was applied alone (1 nM2100 mM) it induced no
discernible current (data not shown). At concentrations of 10 nM
to 100 mM, it reduced the response of the three receptor variants
(RDLbd, RDLbdI/V, RDLbdI/VA
301S) to GABA in a concentra-
tion-dependent manner (Fig. 4A). The pIC50s for fipronil on the 3
isoforms were RDLbd=6.4860.13; RDLbdI/V=6.2060.44;
RDLbdI/VA
301S=5.8060.28. These values were not significantly
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I283V receptor, 1 mM fipronil effected in a 75% reduction of the
response to 50 mM GABA, this was not achieved in the RDLbdI/
VA
301S receptor (50% reduction). Pyrafluprole also reduced the
amplitude of GABA responses at concentrations of 10 nM to
100 mM (Fig. 4B). The estimated pIC50s were
RDLbd=6.2060.34; RDLbdI/V=7.2060.36; RDLbdI/
VA
301S=6.2160.16. These values were not significantly different
one from another (F(2,27)=2.46, P=0.10). All 3 antagonists
completely abolished GABA responses in all RDL isoforms at
100 mM.
All three RDL receptors showed no response to 10 mM IVM
applied alone (data not shown). However, when co-applied with
100 mM GABA, the three RDL receptor variants showed a
reduced response to GABA. When exposed to IVM, all three
receptors produced a concentration-dependent suppression of
amplitude to GABA (Fig. 5) with the following
pIC50s=RDLbd=6.2860.13, RDLbdI/V=6.3360.12 and
RDLbdI/VA
301S=5.9260.09. These values were significantly
different one from another (F(2,51)=5.13, P,0.001).
Discussion
We have characterised aspects of the pharmacology of the most
abundantly expressed isoform of Drosophila RDL variant RDLbdI/
V, exploring for the first time the agonist profile and the actions of
other important ligands including picrotoxin, fipronil and IVM.
Figure 2. Binding models for the different agonists. (A) Overall structure of the homology model of RDLbd. Chains A and E are shown in
cartoon representation, A in orange and E in cyan. Chains B, C and D are shown in spacefill representation in three different shades of grey. The
agonist-binding site is indicated by the sidechains of R111 in chain A (light orange spacefill) and D204 in chain E (light cyan spacefill). (B–G): binding
models for the docked agonists. The agonists are shown with grey carbon atoms, and relevant protein sidechains from chain A and chain E are shown
with light orange and light blue carbon atoms, respectively. Only polar hydrogen atoms on agonists and sidechains are included. Potential hydrogen
bonds (,3A ˚) between ligand and protein are marked with black lines. (H) Superposition of the binding models in (B–F). The conformations of R111
and E204 shown are from the GABA binding model.
doi:10.1371/journal.pone.0097468.g002
Figure 3. Concentration-inhibition curves showing responses
elicited by PTX to 1 mM GABA in RDL, RDLbdIV and RDLbdIV/
A
301S. Each data point was normalised to the amplitude of the
response to 1 mM GABA and represents the mean amplitude of the
responses recorded in 7–13 oocytes from at least 3 separate batches.
Structures of the two compounds found in picrotoxin (PTX), picrotox-
inin and picrotin, are shown.
doi:10.1371/journal.pone.0097468.g003
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abundant native variant in D. melanogaster and also found the single
I283V edit to be the most prevalent isoform. I283V is located in
the intracellular region close to the transmembrane region of
TM1. That region of the subunit may contribute to the pathway of
the permeating ion [36]. When compared with the RDLbd wild-
type, the addition of this edit had no significant effect on the EC50
of GABA. This was also observed by Jones et al. [18]. The RDL
EC50 value recorded here is very similar to previously reported
EC50 values of 56.9 mM [21] and 54 mM [18]. Here we found no
statistically-significant effect of the addition of the A
301S mutation
on the GABA EC50. This is in contrast to Le Goff et al. [15], who
detected a decrease in GABA EC50 from 70 mMt o2 6mM with
the addition of the A
301G mutation in RDLbdR
122G.
Drosophila RDLac and RDLbdI/V have a similar order of agonist
potency [37], i.e. with GABA as the most potent agonist followed
by muscimol, TACA, isoguvacine and lastly b-alanine. However,
we did not see differences between the pEC50 values for GABA
between the 3 different isoforms of RDL that we tested. In
contrast, the EC50 values of agonists for the insect (Musca) bd type
of receptors have been reported to be larger than those of RDLbd
[38] and Dm RDLac [39], although care is needed when
comparing studies performed by different laboratories under
different conditions and on different insect species. The alternative
splicing of exon 6 (resulting in exons c or d) is likely to influence
agonist potency as it generates diversity in loops C and F that
contribute to the ligand-binding site [40].
From our docking calculations it appears likely that the five
agonists studied bind to and activate RDLbd through the same
overall binding mode as suggested by Fig. 2H. A recent study of
the human GABAA receptor likewise suggests that GABA and
muscimol bind with the same overall orientation [41], in a manner
similar to our binding models. The lower potency of TACA and b-
alanine relative to GABA might be explained by a lower binding
affinity as predicted by the docking results (best affinities for
GABA, TACA and b-alanine are 25.0 kcal/mol, 24.7 kcal/mol
and 24.3 kcal/mol, respectively). The explanation for the lower
potency of muscimol and isoguvacine relative to GABA on the
other hand cannot be explained by the binding affinities predicted
by the model (best affinity for muscimol is 25.2 kcal/mol and for
isoguvacine either 25.5 kcal/mol for the less GABA like binding
mode or 25.2 for the GABA like binding mode). The ring systems
in both of these structures may interfere with some of the structural
changes expected for the protein upon activation, however, the
study of the dynamics is beyond the scope of this paper.
Insects showing high resistance to dieldrin also show reduced
sensitivity to picrotoxin and the phenylpyrazoles, fipronil and
pyrafluprole. This is also observed for RDLbdI/V, where the
A
301S mutation causes a 6-fold resistance to picrotoxin, 3-fold
resistance to fipronil and 2-fold resistance to pyrafluprole
compared to wild-type. Binding of picrotoxin in the pore region
close to residues corresponding to A301 has been observed in the
crystal structure of the C. elegans GluCla glutamate-gated chloride
channel [24]. The addition of the I/V edit had no significant effect
on the IC50s, which might be expected as I283V is located in TM1
and is not in contact with the pore-lining TM2 region where A
301S
is located.
IVM is known to interact with GABA receptors and several
reports suggest that insect RDL and GluCl subunits co-assemble to
form IVM-sensitive receptors [38,42,43]. A population of IVM-
Figure 4. Concentration-inhibition curves showing responses
elicited by the phenylpyrazoles (A) fipronil and (B) pyraflu-
prole to 1 mM GABA in wild-type, RDLbdIV and RDLbdIV/A
301S.
Each point represents the mean amplitude of the responses recorded in
2–13 oocytes from at least 3 separate batches. Structures of the two
phenylpyrazoles are inserted.
doi:10.1371/journal.pone.0097468.g004
Figure 5. Effect of ivermectin on RDLbd. Concentration inhibition
curves showing responses elicited by IVM to 100 mM GABA in wild-type,
RDLbdIV and RDLbdIV/A
301S. Each point represents the mean amplitude
of the responses recorded in 2–6 oocytes from at least 3 separate
batches. The structure of ivermectin is inserted.
doi:10.1371/journal.pone.0097468.g005
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DmGluCl1a but lacking DmRDL [42]. RDLbd shows sensitivity to
IVM when investigated as an antagonist. Musca domestica RDLbd
has also been investigated functionally [38], and the values
obtained for its pEC50 (4.0) were similar to those obtained for
Drosophila RDLbd (4.24). However, the authors did not test for
antagonist action of IVM.
It has been shown here that the I/V edit per se has no effect on
IVM actions on RDLbdI/V, but the addition of the A
301S
mutation resulted in 2-fold resistance. This is similar to
observations by Kane et al. [44] who observed that Drosophila
carrying the RDLA
301S mutation were 3.3-fold resistant to IVM
compared to the wild-type. Studies on invertebrate ligand-gated
chloride channels have identified several point mutations that
affect their IVM sensitivity (See [45] for a recent review). Recent
papers on different Cys-loop receptors from a variety of species
have shown that amino acid residues in the TM2–TM3 loop and
in transmembrane regions contribute to high affinity interactions
between the receptor and allosteric ligands such as IVM [46–48].
Lynagh and Lynch [49] identified a single mutation, A288G, in
the human glycine a1 receptor, increasing IVM sensitivity almost
100-fold while Drosophila carrying the P299S mutation in GluCl
(located in the TM2–TM3 loop) are ten-fold less sensitive to IVM
[44]. Modelling by Hibbs and Gouaux [24] showed that IVM
makes contact with the TM2 pore-lining helix and the TM2–TM3
loop. In C. elegans, GluCla Ser260 located in TM2 hydrogen bonds
with IVM. It is interesting to note that for other Cys-loop
receptors, including the glycine and GABAA receptors, that are
directly activated by IVM [50,51], there is also a serine at the
equivalent position to S250 in GluCla.
We report the first pharmacological characterization of the
predominantly expressed native splice and edit variant of the
Drosophila GABA receptor (RDLbdI/V). The I/V edit does not
impact greatly on the potency of GABA or the actions of GABA
agonists. TACA and b-alanine are predicted from molecular
modelling based on the C. elegans GluCl structure to bind with
lower affinity than GABA explaining their lower potency in
functional studies. The results for muscimol and isoguvacine are
less readily explained structurally, and we are forced to speculate
that it may relate to the efficiency with which these ligands induce
the conformational change associated with the opening of the
channel.
The A
301S mutation reduced sensitivity to picrotoxin, fipronil
and pyrafluprole but the I/V edit had no effect. The I/V edit did
not impact on the blocking actions of IVM but the A
301S mutation
modified IVM IC50 values. We speculate that these effects are
subtle modulations of the underlying dynamics and thus will
require much more detailed exploration than is possible here.
Author Contributions
Conceived and designed the experiments: PB DS SDB. Performed the
experiments: KL MM SS. Analyzed the data: PB SDB. Wrote the paper:
KL SDB DS.
References
1. Miller PS, Smart TG (2010) Binding, activation and modulation of Cys-loop
receptors. Trends Pharmacol Sci 31: 161–174.
2. Smart TG (1980) Do motor-nerve terminals have gamma-aminobutyric acid
receptors? Br J Pharmacol 71: 279–286.
3. Accardi MV, Beech RN, Forrester SG (2012) Nematode cys-loop GABA
receptors: biological function, pharmacology and sites of action for anthelmin-
tics. Invert Neurosci 12: 3–12.
4. Hosie AM, Aronstein K, Sattelle DB, ffrench-Constant RH (1997) Molecular
biology of insect neuronal GABA receptors. Trends Neurosci 20: 578–583.
5. Sattelle DB (1990) GABA receptors of insects. Advances in insect physiology 22:
1–113.
6. Gielen MC, Lumb MJ, Smart TG (2012) Benzodiazepines modulate GABAA
receptors by regulating the preactivation step after GABA binding. J Neurosci
32: 5707–5715.
7. Trapani G, Latrofa A, Franco M, Altomare C, Sanna E, et al. (1998) Propofol
analogues. Synthesis, relationships between structure and affinity at GABAA
receptor in rat brain, and differential electrophysiological profile at recombinant
human GABAA receptors. J Med Chem 41: 1846–1854.
8. Hosie AM, Buckingham SD, Hamon A, Sattelle DB (2006) Replacement of
asparagine with arginine at the extracellular end of the second transmembrane
(M2) region of insect GABA receptors increases sensitivity to penicillin G. Invert
Neurosci 6: 75–79.
9. Martin RJ (1982) Electrophysiological effects of piperazine and diethylcarbam-
azine on Ascaris suum somatic muscle. Br J Pharmacol 77: 255–265.
10. Ffrench-Constant RH, Rocheleau TA, Steichen JC, Chalmers AE (1993) A
point mutation in a Drosophila GABA receptor confers insecticide resistance.
Nature 363: 449–451.
11. Ffrench-Constant RH, Mortlock DP, Shaffer CD, MacIntyre RJ, Roush RT
(1991) Molecular cloning and transformation of cyclodiene resistance in
Drosophila: an invertebrate gamma-aminobutyric acid subtype A receptor
locus. Proc Natl Acad Sci U S A 88: 7209–7213.
12. Anthony N, Unruh T, Ganser D, ffrench-Constant R (1998) Duplication of the
Rdl GABA receptor subunit gene in an insecticide-resistant aphid, Myzus persicae.
Mol Gen Genet 260: 165–175.
13. Bass C, Schroeder I, Turberg A, Field LM, Williamson MS (2004) Identification
of the Rdl mutation in laboratory and field strains of the cat flea, Ctenocephalides
felis (Siphonaptera: Pulicidae). Pest Manag Sci 60: 1157–1162.
14. Miyazaki M, Matsumura F, Beeman RW (1995) DNA sequence and site of
mutation of the GABA receptor of cyclodiene-resistant red flour beetle, Tribolium
castaneum. Comp Biochem Physiol B Biochem Mol Biol 111: 399–406.
15. Le Goff G, Hamon A, Berge JB, Amichot M (2005) Resistance to fipronil in
Drosophila simulans: influence of two point mutations in the RDL GABA receptor
subunit. J Neurochem 92: 1295–1305.
16. Andreev D, Kreitman M, Phillips TW, Beeman RW, ffrench-Constant RH
(1999) Multiple origins of cyclodiene insecticide resistance in Tribolium castaneum
(Coleoptera: Tenebrionidae). J Mol Evol 48: 615–624.
17. Ffrench-Constant RH, Roush RT, Mortlock D, Dively GP (1990) Isolation of
dieldrin resistance from field populations of Drosophila melanogaster (Diptera:
Drosophilidae). J Econ Entomol 83: 1733–1737.
18. Jones AK, Buckingham SD, Papadaki M, Yokota M, Sattelle BM, et al. (2009)
Splice-variant- and stage-specific RNA editing of the Drosophila GABA receptor
modulates agonist potency. J Neurosci 29: 4287–4292.
19. Hosie AM, Buckingham SD, Presnail JK, Sattelle DB (2001) Alternative splicing
of a Drosophila GABA receptor subunit gene identifies determinants of agonist
potency. Neuroscience 102: 709–714.
20. Hoopengardner B, Bhalla T, Staber C, Reenan R (2003) Nervous system targets
of RNA editing identified by comparative genomics. Science 301: 832–836.
21. Es-Salah Z, Lapied B, Le Goff G, Hamon A (2008) RNA editing regulates insect
gamma-aminobutyric acid receptor function and insecticide sensitivity. Neu-
roreport 19: 939–943.
22. Fisher JL (2004) The alpha 1 and alpha 6 subunit subtypes of the mammalian
GABA(A) receptor confer distinct channel gating kinetics. J Physiol 561: 433–
448.
23. Sali A, Fiser A, Yerkovich B, Eswar N, Marti-Renom M, et al. (1994) Modeller.
A program for protein structure modelling by satisfaction of spatial restraints.
24. Hibbs RE, Gouaux E (2011) Principles of activation and permeation in an
anion-selective Cys-loop receptor. Nature 474: 54–60.
25. Goujon M, McWilliam H, Li W, Valentin F, Squizzato S, et al. (2010) A new
bioinformatics analysis tools framework at EMBL-EBI. Nucleic Acids Res 38:
W695–699.
26. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, et al. (2007)
Clustal W and Clustal X version 2.0. Bioinformatics 23: 2947–2948.
27. Boulanger T, Vercauteren DP, Durant F, Andre JM (1987) 3- and 5-isoxazolol
zwitterions: an ab initio molecular orbital study relating to GABA agonism and
antagonism. J Theor Biol 127: 479–489.
28. Brehm L, Hjeds H, Krogsgaard-Larsen P (1972) The structure of muscimol, a
GABA analogue of restricted conformation. Acta Chem Scand 26: 1298–1299.
29. King MT (2003) Thermodynamics of the reduction of NADP with 2-propanol
catalyzed by an NADP-dependent alcohol dehydrogenase. Arch Biochem
Biophys 410: 280–286.
30. Krogsgaard-Larsen P, Falch E (1981) GABA agonists. Development and
interactions with the GABA receptor complex. Mol Cell Biochem 38 Spec No:
129–146.
31. Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, et al. (2009)
AutoDock4 and AutoDockTools4: Automated docking with selective receptor
flexibility. J Comput Chem 30: 2785–2791.
Ligand Actions on an Insect GABA Receptor
PLOS ONE | www.plosone.org 7 May 2014 | Volume 9 | Issue 5 | e9746832. Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of
docking with a new scoring function, efficient optimization, and multithreading.
J Comput Chem 31: 455–461.
33. Melis C, Lummis SC, Molteni C (2008) Molecular dynamics simulations of
GABA binding to the GABAC receptor: the role of Arg104. Biophys J 95: 4115–
4123.
34. Osolodkin DI, Chupakhin VI, Palyulin VA, Zefirov NS (2009) Molecular
modeling of ligand-receptor interactions in GABA C receptor. J Mol Graph
Model 27: 813–821.
35. Lummis SC, McGonigle I, Ashby JA, Dougherty DA (2011) Two amino acid
residues contribute to a cation-pi binding interaction in the binding site of an
insect GABA receptor. J Neurosci 31: 12371–12376.
36. Filippova N, Wotring VE, Weiss DS (2004) Evidence that the TM1–TM2 loop
contributes to the rho1 GABA receptor pore. J Biol Chem 279: 20906–20914.
37. Hosie AM, Sattelle DB (1996) Agonist pharmacology of two Drosophila GABA
receptor splice variants. Br J Pharmacol 119: 1577–1585.
38. Eguchi Y, Ihara M, Ochi E, Shibata Y, Matsuda K, et al. (2006) Functional
characterization of Musca glutamate- and GABA-gated chloride channels
expressed independently and coexpressed in Xenopus oocytes. Insect Mol Biol
15: 773–783.
39. McGonigle I, Lummis SC (2010) Molecular characterization of agonists that
bind to an insect GABA receptor. Biochemistry 49: 2897–2902.
40. Buckingham SD, Biggin PC, Sattelle BM, Brown LA, Sattelle DB (2005) Insect
GABA receptors: splicing, editing, and targeting by antiparasitics and
insecticides. Mol Pharmacol 68: 942–951.
41. Bergmann R, Kongsbak K, Sorensen PL, Sander T, Balle T (2013) A unified
model of the GABA(A) receptor comprising agonist and benzodiazepine binding
sites. PLoS One 8: e52323.
42. Ludmerer SW, Warren VA, Williams BS, Zheng Y, Hunt DC, et al. (2002)
Ivermectin and nodulisporic acid receptors in Drosophila melanogaster contain both
gamma-aminobutyric acid-gated Rdl and glutamate-gated GluCl alpha chloride
channel subunits. Biochemistry 41: 6548–6560.
43. Zhao X, Salgado VL (2010) The role of GABA and glutamate receptors in
susceptibility and resistance to chloride channel blocker insecticides. Pesticide
biochemistry and physiology 97: 153–160.
44. Kane NS, Hirschberg B, Qian S, Hunt D, Thomas B, et al. (2000) Drug-resistant
Drosophila indicate glutamate-gated chloride channels are targets for the
antiparasitics nodulisporic acid and ivermectin. Proc Natl Acad Sci U S A 97:
13949–13954.
45. Wolstenholme AJ (2012) Glutamate-gated chloride channels. J Biol Chem 287:
40232–40238.
46. Krause RM, Buisson B, Bertrand S, Corringer PJ, Galzi JL, et al. (1998)
Ivermectin: a positive allosteric effector of the alpha7 neuronal nicotinic
acetylcholine receptor. Mol Pharmacol 53: 283–294.
47. Sattelle DB, Buckingham SD, Akamatsu M, Matsuda K, Pienaar IS, et al. (2009)
Comparative pharmacology and computational modelling yield insights into
allosteric modulation of human alpha7 nicotinic acetylcholine receptors.
Biochem Pharmacol 78: 836–843.
48. Wolstenholme AJ (2010) Recent progress in understanding the interaction
between avermectins and ligand-gated ion channels: putting the pests to sleep.
Invert Neurosci 10: 5–10.
49. Lynagh T, Lynch JW (2010) An improved ivermectin-activated chloride channel
receptor for inhibiting electrical activity in defined neuronal populations. J Biol
Chem 285: 14890–14897.
50. Adelsberger H, Lepier A, Dudel J (2000) Activation of rat recombinant
alpha(1)beta(2)gamma(2S) GABA(A) receptor by the insecticide ivermectin.
Eur J Pharmacol 394: 163–170.
51. Shan Q, Haddrill JL, Lynch JW (2001) Ivermectin, an unconventional agonist of
the glycine receptor chloride channel. Journal of Biological Chemistry 276:
12556–12564.
Ligand Actions on an Insect GABA Receptor
PLOS ONE | www.plosone.org 8 May 2014 | Volume 9 | Issue 5 | e97468